RXi Shortens Strands for Effective Drug Delivery

Geert Cauwenbergh, President & CEO for RXi Pharmaceuticals, shares the company’s role in making RNAI relevant to ophthalmology. Highlighting their research surrounding the delivery of drug to the eye, Geert expands on their unique modification to create shorter passenger strands to accompany the longer guide strand to facilitate delivery to the eye effectively. Presenter: Geert…

Read More

Aerie Advances to the Next Round in Glaucoma Treatment

Vicente Anido Jr. PhD, Chairman & CEO for Aerie Pharmaceuticals, provides the attendees of the 5th Annual Ophthalmology Innovation Summit with an overview of Aeries rapid changes throughout the past year. Aerie focuses on the treatment of Glaucoma and has two major products, AR-1324 and Latanapross. Having just completed their initial Public Offering, Aerie can…

Read More

CheckedUp Digitizes Communication in Eye Care

Richard Awdeh MD, Founder & CEO for CheckUp, begins by sharing the high number of patients that ophthalmologists see each day and the incredibly low average of time an ophthalmologist has to spend with each patient. Utilizing technology to enhance communication between patient and doctor, Richard explains how his digital communication platform can enhance the…

Read More

Large Device Companies Eyeing Opportunities in Ophthalmic Space

NEW ORLEANS — The oft-repeated Cajun expression in this fun loving town, ”laissez les bon temps roulez,” translated as let the good times roll may be an accurate way of summarizing the upbeat mood at this year’s annual meeting of the American Academy of Ophthalmology (AAO; San Francisco). The AAO is by far the largest…

Read More